Document is current
Any future updates will be listed below
-
Authors
Hasegawa, Juri https://orcid.org/0000-0001-7799-4216
Nagata, Tetsuya https://orcid.org/0000-0003-4111-2693
Ihara, Kensuke https://orcid.org/0000-0002-2436-9588
Tanihata, Jun
Ebihara, Satoe
Yoshida-Tanaka, Kie
Yanagidaira, Mitsugu
Ohara, Masahiro https://orcid.org/0000-0003-0344-251X
Sasaki, Asuka
Nakayama, Miyu https://orcid.org/0000-0001-9154-1934
Yamamoto, Syunsuke https://orcid.org/0000-0002-0257-1216
Ishii, Takashi
Iwata-Hara, Rintaro https://orcid.org/0000-0003-2399-3431
Naito, Mitsuru https://orcid.org/0000-0002-4237-871X
Miyata, Kanjiro https://orcid.org/0000-0001-7044-190X
Sakaue, Fumika
Yokota, Takanori https://orcid.org/0000-0002-6490-3263
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (23am0401006h0005)
MEXT | Japan Society for the Promotion of Science (19H01016, 19H01016, 22H00440, 16H05221)
Joint Research Fund with Takeda Pharmaceutical Company, Limited.
- License Information
-
More Information
Article History
Received: 2 March 2023
Accepted: 23 April 2024
First Online: 26 September 2024
Competing interests
: T.Y. has ongoing collaborations with Takeda Pharmaceutical Co., Ltd. and serves as an academic advisor for Rena Therapeutics Inc. The other authors declare no competing interests. M.N. and S.S. are paid employees of Takeda Pharmaceutical Company Limited.
